Day Range2.965 - 3.300 | 52 Wk Range1.050 - 13.910 | Open / Close3.220 / - | Float / Outstanding- / 37.446M |
Vol / Avg.84.666K / 75.071K | Mkt Cap112.712M | P/E- | 50d Avg. Price2.100 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.600 |
Renalytix Stock (NASDAQ: RNLX) stock price, news, charts, stock research, profile.
Day Range2.965 - 3.300 | 52 Wk Range1.050 - 13.910 | Open / Close3.220 / - | Float / Outstanding- / 37.446M |
Vol / Avg.84.666K / 75.071K | Mkt Cap112.712M | P/E- | 50d Avg. Price2.100 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.600 |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-30 | ||||||
REV |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.130 | -0.160 | -0.0300 | ||||
REV | 1.100M | 969.000K | -131.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Renalytix (NASDAQ: RNLX) through any online brokerage.
Other companies in Renalytix’s space includes: MultiPlan (NYSE:MPLN), OptimizeRx (NASDAQ:OPRX), Pear Therapeutics (NASDAQ:PEAR), CareCloud (NASDAQ:CCLD) and Better Therapeutics (NASDAQ:BTTX).
The latest price target for Renalytix (NASDAQ: RNLX) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 8.00 expecting RNLX to rise to within 12 months (a possible 165.78% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Renalytix (NASDAQ: RNLX) is $3.01 last updated Today at January 31, 2023 at 5:51 PM UTC.
There are no upcoming dividends for Renalytix.
Renalytix’s Q2 earnings are confirmed for Thursday, March 30, 2023.
There is no upcoming split for Renalytix.
Renalytix is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Renalytix Stock (NASDAQ: RNLX) stock price, news, charts, stock research, profile.
Day Range2.965 - 3.300 | 52 Wk Range1.050 - 13.910 | Open / Close3.220 / - | Float / Outstanding- / 37.446M |
Vol / Avg.84.666K / 75.071K | Mkt Cap112.712M | P/E- | 50d Avg. Price2.100 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.600 |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-30 | ||||||
REV |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.130 | -0.160 | -0.0300 | ||||
REV | 1.100M | 969.000K | -131.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Renalytix (NASDAQ: RNLX) through any online brokerage.
Other companies in Renalytix’s space includes: MultiPlan (NYSE:MPLN), OptimizeRx (NASDAQ:OPRX), Pear Therapeutics (NASDAQ:PEAR), CareCloud (NASDAQ:CCLD) and Better Therapeutics (NASDAQ:BTTX).
The latest price target for Renalytix (NASDAQ: RNLX) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 8.00 expecting RNLX to rise to within 12 months (a possible 165.78% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Renalytix (NASDAQ: RNLX) is $3.01 last updated Today at January 31, 2023 at 5:51 PM UTC.
There are no upcoming dividends for Renalytix.
Renalytix’s Q2 earnings are confirmed for Thursday, March 30, 2023.
There is no upcoming split for Renalytix.
Renalytix is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Renalytix Stock (NASDAQ: RNLX) stock price, news, charts, stock research, profile.
Day Range2.965 - 3.300 | 52 Wk Range1.050 - 13.910 | Open / Close3.220 / - | Float / Outstanding- / 37.446M |
Vol / Avg.84.666K / 75.071K | Mkt Cap112.712M | P/E- | 50d Avg. Price2.100 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.600 |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-30 | ||||||
REV |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.130 | -0.160 | -0.0300 | ||||
REV | 1.100M | 969.000K | -131.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Renalytix (NASDAQ: RNLX) through any online brokerage.
Other companies in Renalytix’s space includes: MultiPlan (NYSE:MPLN), OptimizeRx (NASDAQ:OPRX), Pear Therapeutics (NASDAQ:PEAR), CareCloud (NASDAQ:CCLD) and Better Therapeutics (NASDAQ:BTTX).
The latest price target for Renalytix (NASDAQ: RNLX) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 8.00 expecting RNLX to rise to within 12 months (a possible 165.78% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Renalytix (NASDAQ: RNLX) is $3.01 last updated Today at January 31, 2023 at 5:51 PM UTC.
There are no upcoming dividends for Renalytix.
Renalytix’s Q2 earnings are confirmed for Thursday, March 30, 2023.
There is no upcoming split for Renalytix.
Renalytix is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Renalytix Stock (NASDAQ: RNLX) stock price, news, charts, stock research, profile.
Day Range2.965 - 3.300 | 52 Wk Range1.050 - 13.910 | Open / Close3.220 / - | Float / Outstanding- / 37.446M |
Vol / Avg.84.666K / 75.071K | Mkt Cap112.712M | P/E- | 50d Avg. Price2.100 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.600 |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-30 | ||||||
REV |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.130 | -0.160 | -0.0300 | ||||
REV | 1.100M | 969.000K | -131.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Renalytix (NASDAQ: RNLX) through any online brokerage.
Other companies in Renalytix’s space includes: MultiPlan (NYSE:MPLN), OptimizeRx (NASDAQ:OPRX), Pear Therapeutics (NASDAQ:PEAR), CareCloud (NASDAQ:CCLD) and Better Therapeutics (NASDAQ:BTTX).
The latest price target for Renalytix (NASDAQ: RNLX) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 8.00 expecting RNLX to rise to within 12 months (a possible 165.78% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Renalytix (NASDAQ: RNLX) is $3.01 last updated Today at January 31, 2023 at 5:51 PM UTC.
There are no upcoming dividends for Renalytix.
Renalytix’s Q2 earnings are confirmed for Thursday, March 30, 2023.
There is no upcoming split for Renalytix.
Renalytix is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Renalytix Stock (NASDAQ: RNLX) stock price, news, charts, stock research, profile.
Day Range2.965 - 3.300 | 52 Wk Range1.050 - 13.910 | Open / Close3.220 / - | Float / Outstanding- / 37.446M |
Vol / Avg.84.666K / 75.071K | Mkt Cap112.712M | P/E- | 50d Avg. Price2.100 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.600 |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-30 | ||||||
REV |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.130 | -0.160 | -0.0300 | ||||
REV | 1.100M | 969.000K | -131.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Renalytix (NASDAQ: RNLX) through any online brokerage.
Other companies in Renalytix’s space includes: MultiPlan (NYSE:MPLN), OptimizeRx (NASDAQ:OPRX), Pear Therapeutics (NASDAQ:PEAR), CareCloud (NASDAQ:CCLD) and Better Therapeutics (NASDAQ:BTTX).
The latest price target for Renalytix (NASDAQ: RNLX) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 8.00 expecting RNLX to rise to within 12 months (a possible 165.78% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Renalytix (NASDAQ: RNLX) is $3.01 last updated Today at January 31, 2023 at 5:51 PM UTC.
There are no upcoming dividends for Renalytix.
Renalytix’s Q2 earnings are confirmed for Thursday, March 30, 2023.
There is no upcoming split for Renalytix.
Renalytix is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Renalytix Stock (NASDAQ: RNLX) stock price, news, charts, stock research, profile.
Day Range2.965 - 3.300 | 52 Wk Range1.050 - 13.910 | Open / Close3.220 / - | Float / Outstanding- / 37.446M |
Vol / Avg.84.666K / 75.071K | Mkt Cap112.712M | P/E- | 50d Avg. Price2.100 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.600 |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-30 | ||||||
REV |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.130 | -0.160 | -0.0300 | ||||
REV | 1.100M | 969.000K | -131.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Renalytix (NASDAQ: RNLX) through any online brokerage.
Other companies in Renalytix’s space includes: MultiPlan (NYSE:MPLN), OptimizeRx (NASDAQ:OPRX), Pear Therapeutics (NASDAQ:PEAR), CareCloud (NASDAQ:CCLD) and Better Therapeutics (NASDAQ:BTTX).
The latest price target for Renalytix (NASDAQ: RNLX) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 8.00 expecting RNLX to rise to within 12 months (a possible 165.78% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Renalytix (NASDAQ: RNLX) is $3.01 last updated Today at January 31, 2023 at 5:51 PM UTC.
There are no upcoming dividends for Renalytix.
Renalytix’s Q2 earnings are confirmed for Thursday, March 30, 2023.
There is no upcoming split for Renalytix.
Renalytix is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Renalytix Stock (NASDAQ: RNLX) stock price, news, charts, stock research, profile.
Day Range2.965 - 3.300 | 52 Wk Range1.050 - 13.910 | Open / Close3.220 / - | Float / Outstanding- / 37.446M |
Vol / Avg.84.666K / 75.071K | Mkt Cap112.712M | P/E- | 50d Avg. Price2.100 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.600 |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-30 | ||||||
REV |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.130 | -0.160 | -0.0300 | ||||
REV | 1.100M | 969.000K | -131.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Renalytix (NASDAQ: RNLX) through any online brokerage.
Other companies in Renalytix’s space includes: MultiPlan (NYSE:MPLN), OptimizeRx (NASDAQ:OPRX), Pear Therapeutics (NASDAQ:PEAR), CareCloud (NASDAQ:CCLD) and Better Therapeutics (NASDAQ:BTTX).
The latest price target for Renalytix (NASDAQ: RNLX) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 8.00 expecting RNLX to rise to within 12 months (a possible 165.78% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Renalytix (NASDAQ: RNLX) is $3.01 last updated Today at January 31, 2023 at 5:51 PM UTC.
There are no upcoming dividends for Renalytix.
Renalytix’s Q2 earnings are confirmed for Thursday, March 30, 2023.
There is no upcoming split for Renalytix.
Renalytix is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Renalytix Stock (NASDAQ: RNLX) stock price, news, charts, stock research, profile.
Day Range2.965 - 3.300 | 52 Wk Range1.050 - 13.910 | Open / Close3.220 / - | Float / Outstanding- / 37.446M |
Vol / Avg.84.666K / 75.071K | Mkt Cap112.712M | P/E- | 50d Avg. Price2.100 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.600 |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-30 | ||||||
REV |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.130 | -0.160 | -0.0300 | ||||
REV | 1.100M | 969.000K | -131.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Renalytix (NASDAQ: RNLX) through any online brokerage.
Other companies in Renalytix’s space includes: MultiPlan (NYSE:MPLN), OptimizeRx (NASDAQ:OPRX), Pear Therapeutics (NASDAQ:PEAR), CareCloud (NASDAQ:CCLD) and Better Therapeutics (NASDAQ:BTTX).
The latest price target for Renalytix (NASDAQ: RNLX) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 8.00 expecting RNLX to rise to within 12 months (a possible 165.78% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Renalytix (NASDAQ: RNLX) is $3.01 last updated Today at January 31, 2023 at 5:51 PM UTC.
There are no upcoming dividends for Renalytix.
Renalytix’s Q2 earnings are confirmed for Thursday, March 30, 2023.
There is no upcoming split for Renalytix.
Renalytix is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Renalytix Stock (NASDAQ: RNLX) stock price, news, charts, stock research, profile.
Day Range2.965 - 3.300 | 52 Wk Range1.050 - 13.910 | Open / Close3.220 / - | Float / Outstanding- / 37.446M |
Vol / Avg.84.666K / 75.071K | Mkt Cap112.712M | P/E- | 50d Avg. Price2.100 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.600 |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-30 | ||||||
REV |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.130 | -0.160 | -0.0300 | ||||
REV | 1.100M | 969.000K | -131.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Renalytix (NASDAQ: RNLX) through any online brokerage.
Other companies in Renalytix’s space includes: MultiPlan (NYSE:MPLN), OptimizeRx (NASDAQ:OPRX), Pear Therapeutics (NASDAQ:PEAR), CareCloud (NASDAQ:CCLD) and Better Therapeutics (NASDAQ:BTTX).
The latest price target for Renalytix (NASDAQ: RNLX) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 8.00 expecting RNLX to rise to within 12 months (a possible 165.78% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Renalytix (NASDAQ: RNLX) is $3.01 last updated Today at January 31, 2023 at 5:51 PM UTC.
There are no upcoming dividends for Renalytix.
Renalytix’s Q2 earnings are confirmed for Thursday, March 30, 2023.
There is no upcoming split for Renalytix.
Renalytix is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.